The policies and approaches healthcare leaders should promote.
Thomas E. Henry III, MBA, RPh, CPh
Advertisement
Articles by Thomas E. Henry III, MBA, RPh, CPh
Advertisement
Latest Updated Articles
Four Opportunities to Tap into Biosimilar Cost SavingsSeptember 10th 2019
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Pope Leo XIV's lung cancer diagnosis puts a spotlight on low U.S. screening rates
2
Chronic hand eczema needs more than topical steroids | Fall Clinical Derm 2026
3
Why biosimilars keep losing ground to brand-name rivals: A Q&A with Christine Johnston, MBA
4
U.S. employer-covered healthcare costs: It’s still the prices
5